Researcher’s Profile

Julia J. Wattacheril, MD, MPH

Director of the Nonalcoholic Fatty Liver Disease Program

Hepatic steatosis, insulin resistance and metabolic liver disease in adults. Her current grant concentrates on the proteins and lipids that signal the transition from steatosis to steatohepatitis.

Corey KE, Gawrieh S, deLemos AS, Zheng H, Scanga AE, Haglund JW, Sanchez J, Danford CJ, Comerford M, Bossi K, Munir S, Chalasani N, Wattacheril J. Risk factors for hepato­cellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study. World J Hepatol 2017; 9(7): 385-390
Wattacheril, J, Rose, K. L., Hill, S., Lanciault, C., Murray, C. R., Washington, K., Williams, B., English, W., Spann, M., Clements, R., Abumrad, N., and Flynn, C. R. (2017) NAFLD Phosphoproteomics: A Functional Piece of the Precision Puzzle. Hepatol Res, doi: 10.1111/hepr.12885.
Wattacheril J, Sanyal AJ. Lean NAFLD: An Underrecognized Outlier. Curt Hepatol Rep. 2016 Jun;15(2):134-139, Epub 2016 Apr 14. PMID: 27668144
Guo Y, Xiong Y, Sheng Q, Zhao S, Wattacheril J, Flynn CR. A micro-RNA expression signature for human NAFLD progression. J Gastroenterol. 2016 Feb 13.
Wattacheril, Julia and Joseph Awad. “Acute Management of Portal Hypertensive Bleeding” Jarnagin & Blumgart: Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas 5/e, 2012, 2016

Dr. Wattacheril's clinical specialties include all aspects of transplant hepatology, general hepatology and gastroenterology with emphasis on metabolic liver disease and obesity. She specializes in nonalcoholic fatty liver disease as well as all forms of hepatitis, chronic liver disease, and liver cancer in addition to liver transplantation. Her research interests include hepatic steatosis, insulin resistance, gut hormones and metabolic liver disease in adults. Her current research concentrates on the relationship between proteins and lipids that differentiate steatosis from steatohepatitis using an integrated omics approach.